{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:24:41Z","timestamp":1792783481991,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Henan Clinical Medical Scientist Program","award":["HNCMS202522"],"award-info":[{"award-number":["HNCMS202522"]}]},{"name":"the Natural Science Foundation of China","award":["82570715"],"award-info":[{"award-number":["82570715"]}]},{"name":"the Natural Science Foundation of China","award":["82500766"],"award-info":[{"award-number":["82500766"]}]},{"name":"Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University","award":["ZYCXTD2023010"],"award-info":[{"award-number":["ZYCXTD2023010"]}],"id":[{"id":"https:\/\/ror.org\/056swr059","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s13105-026-01241-8","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:35:46Z","timestamp":1791340546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative metabolomics and malonyl-proteomics reveal the crosstalk between metabolic reprogramming and lysine malonylation in liver fibrosis"],"prefix":"10.1007","volume":"82","author":[{"given":"Yun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiran","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"1241_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea V, Friedman SL (2011) Pathogenesis of liver fibrosis. Annu Rev Pathol 6:425\u2013456. https:\/\/doi.org\/10.1146\/annurev-pathol-011110-130246","journal-title":"Annu Rev Pathol"},{"key":"1241_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19668-y","volume":"11","author":"H Xu","year":"2020","unstructured":"Xu H, Zhao Q, Song N, Yan Z, Lin R, Wu S et al (2020) AdipoR1\/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis. Nat Commun 11:5807. https:\/\/doi.org\/10.1038\/s41467-020-19668-y","journal-title":"Nat Commun"},{"key":"1241_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31987","author":"W Yang","year":"2021","unstructured":"Yang W, He H, Wang T, Su N, Zhang F, Jiang K et al (2021) Single-Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell-Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice. Hepatology. https:\/\/doi.org\/10.1002\/hep.31987","journal-title":"Hepatology"},{"key":"1241_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000182","author":"L Gong","year":"2023","unstructured":"Gong L, Wei F, Gonzalez FJ, Li G (2023) Hepatic fibrosis: targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines. Hepatology. https:\/\/doi.org\/10.1097\/hep.0000000000000182","journal-title":"Hepatology"},{"key":"1241_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/hep.27744","volume":"62","author":"NS Ghonem","year":"2015","unstructured":"Ghonem NS, Assis DN, Boyer JL (2015) Fibrates and cholestasis. Hepatology 62:635\u2013643. https:\/\/doi.org\/10.1002\/hep.27744","journal-title":"Hepatology"},{"key":"1241_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.107864","volume":"190","author":"RB Nahomi","year":"2020","unstructured":"Nahomi RB, Nandi SK, Rakete S, Michel C, Fritz KS, Nagaraj RH (2020) Lysine malonylation and propionylation are prevalent in human lens proteins. Exp Eye Res 190:107864. https:\/\/doi.org\/10.1016\/j.exer.2019.107864","journal-title":"Exp Eye Res"},{"key":"1241_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/BST20150004","volume":"43","author":"E Thinon","year":"2015","unstructured":"Thinon E, Hang HC (2015) Chemical reporters for exploring protein acylation. Biochem Soc Trans 43:253\u2013261. https:\/\/doi.org\/10.1042\/BST20150004","journal-title":"Biochem Soc Trans"},{"key":"1241_CR8","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M111.012658","volume":"10","author":"C Peng","year":"2011","unstructured":"Peng C, Lu Z, Xie Z, Cheng Z, Chen Y, Tan M et al (2011) The first identification of lysine malonylation substrates and its regulatory enzyme. Mol Cell Proteomics 10:M111.012658. https:\/\/doi.org\/10.1074\/mcp.M111.012658","journal-title":"Mol Cell Proteomics"},{"key":"1241_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41467-018-08187-6","volume":"10","author":"S Galvan-Pena","year":"2019","unstructured":"Galvan-Pena S, Carroll RG, Newman C, Hinchy EC, Palsson-McDermott E, Robinson EK et al (2019) Malonylation of GAPDH is an inflammatory signal in macrophages. Nat Commun 10:338. https:\/\/doi.org\/10.1038\/s41467-018-08187-6","journal-title":"Nat Commun"},{"key":"1241_CR10","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.cmet.2018.07.019","volume":"28","author":"U Bruning","year":"2018","unstructured":"Bruning U, Morales-Rodriguez F, Kalucka J, Goveia J, Taverna F, Queiroz KCS et al (2018) Impairment of angiogenesis by fatty acid synthase inhibition involves mTOR malonylation. Cell Metab 28:866-880 e815. https:\/\/doi.org\/10.1016\/j.cmet.2018.07.019","journal-title":"Cell Metab"},{"key":"1241_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1074\/mcp.M114.041947","volume":"14","author":"Y Du","year":"2015","unstructured":"Du Y, Cai T, Li T, Xue P, Zhou B, He X et al (2015) Lysine malonylation is elevated in type 2 diabetic mouse models and enriched in metabolic associated proteins. Mol Cell Proteom 14:227\u2013236. https:\/\/doi.org\/10.1074\/mcp.M114.041947","journal-title":"Mol Cell Proteom"},{"key":"1241_CR12","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021110324","volume":"41","author":"Q Huang","year":"2022","unstructured":"Huang Q, Wu D, Zhao J, Yan Z, Chen L, Guo S et al (2022) TFAM loss induces nuclear actin assembly upon mDia2 malonylation to promote liver cancer metastasis. EMBO J 41:e110324. https:\/\/doi.org\/10.15252\/embj.2021110324","journal-title":"EMBO J"},{"key":"1241_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.molcel.2015.05.022","volume":"59","author":"Y Nishida","year":"2015","unstructured":"Nishida Y, Rardin MJ, Carrico C, He W, Sahu AK, Gut P et al (2015) SIRT5 regulates both cytosolic and mitochondrial protein malonylation with glycolysis as a major target. Mol Cell 59:321\u2013332. https:\/\/doi.org\/10.1016\/j.molcel.2015.05.022","journal-title":"Mol Cell"},{"key":"1241_CR14","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1172\/jci63967","volume":"122","author":"DW Foster","year":"2012","unstructured":"Foster DW (2012) Malonyl-CoA: the regulator of fatty acid synthesis and oxidation. J Clin Investig 122:1958\u20131959. https:\/\/doi.org\/10.1172\/jci63967","journal-title":"J Clin Investig"},{"key":"1241_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.chembiol.2017.04.009","volume":"24","author":"CE Bowman","year":"2017","unstructured":"Bowman CE, Rodriguez S, Selen Alpergin ES, Acoba MG, Zhao L, Hartung T et al (2017) The Mammalian Malonyl-CoA Synthetase ACSF3 Is Required for Mitochondrial Protein Malonylation and Metabolic Efficiency. Cell Chem Biol 24:673\u2013684e674. https:\/\/doi.org\/10.1016\/j.chembiol.2017.04.009","journal-title":"Cell Chem Biol"},{"key":"1241_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1145408","volume":"14","author":"L Liu","year":"2023","unstructured":"Liu L, Hu Q, Zhang Y, Sun X, Sun R, Ren Z (2023) Classification molecular subtypes of hepatocellular carcinoma based on PRMT-related genes. Front Pharmacol 14:1145408. https:\/\/doi.org\/10.3389\/fphar.2023.1145408","journal-title":"Front Pharmacol"},{"key":"1241_CR17","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1039\/c7mb00093f","volume":"13","author":"J Fang","year":"2017","unstructured":"Fang J, Wang L, Wang Y, Qiu M, Zhang Y (2017) Metabolomics combined with pattern recognition and bioinformatics analysis methods for the development of pharmacodynamic biomarkers on liver fibrosis. Mol Biosyst 13:1575\u20131583. https:\/\/doi.org\/10.1039\/c7mb00093f","journal-title":"Mol Biosyst"},{"key":"1241_CR18","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3748\/wjg.v25.i8.941","volume":"25","author":"J Yu","year":"2019","unstructured":"Yu J, He JQ, Chen DY, Pan QL, Yang JF, Cao HC et al (2019) Dynamic changes of key metabolites during liver fibrosis in rats. World J Gastroenterol 25:941\u2013954. https:\/\/doi.org\/10.3748\/wjg.v25.i8.941","journal-title":"World J Gastroenterol"},{"key":"1241_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.devcel.2020.06.036","volume":"54","author":"G Figlia","year":"2020","unstructured":"Figlia G, Willnow P, Teleman AA (2020) Metabolites Regulate Cell Signaling and Growth via Covalent Modification of Proteins. Dev Cell 54:156\u2013170. https:\/\/doi.org\/10.1016\/j.devcel.2020.06.036","journal-title":"Dev Cell"},{"key":"1241_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000005","author":"F Yang","year":"2023","unstructured":"Yang F, Hilakivi-Clarke L, Shaha A, Wang Y, Wang X, Deng Y et al (2023) Metabolic reprogramming and its clinical implication for liver cancer. Hepatology. https:\/\/doi.org\/10.1097\/hep.0000000000000005","journal-title":"Hepatology"},{"key":"1241_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tcb.2022.09.009","volume":"33","author":"M Parlani","year":"2023","unstructured":"Parlani M, Jorgez C, Friedl P (2023) Plasticity of cancer invasion and energy metabolism. Trends Cell Biol 33:388\u2013402. https:\/\/doi.org\/10.1016\/j.tcb.2022.09.009","journal-title":"Trends Cell Biol"},{"key":"1241_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106833","volume":"158","author":"J Qian","year":"2023","unstructured":"Qian J, Wang Y, Liu X, Hu Z, Xu N, Wang Y et al (2023) Improving acetoin production through construction of a genome-scale metabolic model. Comput Biol Med 158:106833. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106833","journal-title":"Comput Biol Med"},{"key":"1241_CR23","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","volume":"73","author":"J Bates","year":"2020","unstructured":"Bates J, Vijayakumar A, Ghoshal S, Marchand B, Yi S, Kornyeyev D et al (2020) Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation. J Hepatol 73:896\u2013905. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.037","journal-title":"J Hepatol"},{"key":"1241_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228212","volume":"15","author":"M Matsumoto","year":"2020","unstructured":"Matsumoto M, Yashiro H, Ogino H, Aoyama K, Nambu T, Nakamura S et al (2020) Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis. PLoS One 15:e0228212. https:\/\/doi.org\/10.1371\/journal.pone.0228212","journal-title":"PLoS One"},{"key":"1241_CR25","doi-asserted-by":"publisher","first-page":"E1796","DOI":"10.1073\/pnas.1520686113","volume":"113","author":"G Harriman","year":"2016","unstructured":"Harriman G, Greenwood J, Bhat S, Huang X, Wang R, Paul D et al (2016) Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats. Proc Natl Acad Sci USA 113:E1796\u20131805. https:\/\/doi.org\/10.1073\/pnas.1520686113","journal-title":"Proc Natl Acad Sci USA"},{"key":"1241_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06614-9","volume":"12","author":"R Gallego-Duran","year":"2022","unstructured":"Gallego-Duran R, Ampuero J, Pastor-Ramirez H, Alvarez-Amor L, Del Campo JA, Maya-Miles D et al (2022) Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation. Sci Rep 12:3418. https:\/\/doi.org\/10.1038\/s41598-022-06614-9","journal-title":"Sci Rep"},{"key":"1241_CR27","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jhep.2018.06.023","volume":"69","author":"F De Chiara","year":"2018","unstructured":"De Chiara F, Heeboll S, Marrone G, Montoliu C, Hamilton-Dutoit S, Ferrandez A et al (2018) Urea cycle dysregulation in non-alcoholic fatty liver disease. J Hepatol 69:905\u2013915. https:\/\/doi.org\/10.1016\/j.jhep.2018.06.023","journal-title":"J Hepatol"},{"key":"1241_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ymgme.2017.02.011","volume":"120","author":"L Wang","year":"2017","unstructured":"Wang L, Bell P, Morizono H, He Z, Pumbo E, Yu H et al (2017) AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous mice. Mol Genet Metab 120:299\u2013305. https:\/\/doi.org\/10.1016\/j.ymgme.2017.02.011","journal-title":"Mol Genet Metab"},{"key":"1241_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41556-021-00818-3","volume":"24","author":"HL Zhang","year":"2022","unstructured":"Zhang HL, Hu BX, Li ZL, Du T, Shan JL, Ye ZP et al (2022) PKCbetaII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis. Nat Cell Biol 24:88\u201398. https:\/\/doi.org\/10.1038\/s41556-021-00818-3","journal-title":"Nat Cell Biol"},{"key":"1241_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010210","author":"EA Ahmed","year":"2022","unstructured":"Ahmed EA, El-Derany MO, Anwar AM, Saied EM, Magdeldin S (2022) Metabolomics and lipidomics screening reveal reprogrammed signaling pathways toward cancer development in non-alcoholic steatohepatitis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24010210","journal-title":"Int J Mol Sci"},{"key":"1241_CR31","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1158\/2326-6066.CIR-19-0261","volume":"8","author":"L Wu","year":"2020","unstructured":"Wu L, Zhang X, Zheng L, Zhao H, Yan G, Zhang Q et al (2020) RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis. Cancer Immunol Res 8:710\u2013721. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0261","journal-title":"Cancer Immunol Res"},{"key":"1241_CR32","doi-asserted-by":"publisher","unstructured":"Gu L, Zhu Y, Lin X, Lu B, Zhou X, Zhou F et al (2021) The IKKbeta-USP30-ACLY Axis Controls Lipogenesis and Tumorigenesis. 73:160\u2013174. https:\/\/doi.org\/10.1002\/hep.31249","DOI":"10.1002\/hep.31249"},{"key":"1241_CR33","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.cmet.2022.05.004","volume":"34","author":"MR Morrow","year":"2022","unstructured":"Morrow MR, Batchuluun B, Wu J, Ahmadi E, Leroux JM, Mohammadi-Shemirani P et al (2022) Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia. Cell Metab 34:919\u2013936. https:\/\/doi.org\/10.1016\/j.cmet.2022.05.004","journal-title":"Cell Metab"},{"key":"1241_CR34","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1053\/j.gastro.2021.07.025","volume":"161","author":"R Loomba","year":"2021","unstructured":"Loomba R, Mohseni R, Lucas KJ, Gutierrez JA, Perry RG, Trotter JF et al (2021) TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled phase 2a trial. Gastroenterology 161:1475\u20131486. https:\/\/doi.org\/10.1053\/j.gastro.2021.07.025","journal-title":"Gastroenterology"},{"key":"1241_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2022.10.005","author":"P Altea-Manzano","year":"2022","unstructured":"Altea-Manzano P, Vandekeere A, Edwards-Hicks J, Roldan M, Abraham E, Lleshi X et al (2022) Reversal of mitochondrial malate dehydrogenase 2 enables anaplerosis via redox rescue in respiration-deficient cells. Mol Cell. https:\/\/doi.org\/10.1016\/j.molcel.2022.10.005","journal-title":"Mol Cell"},{"key":"1241_CR36","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3389\/fendo.2018.00637","volume":"9","author":"J Jezek","year":"2018","unstructured":"Jezek J, Plecita-Hlavata L, Jezek P (2018) Aglycemic HepG2 Cells Switch From Aminotransferase Glutaminolytic Pathway of Pyruvate Utilization to Complete Krebs Cycle at Hypoxia. Front Endocrinol (Lausanne) 9:637. https:\/\/doi.org\/10.3389\/fendo.2018.00637","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1241_CR37","doi-asserted-by":"publisher","unstructured":"Tyszka-Czochara M, Bukowska-Strakova K, Kocemba-Pilarczyk KA, Majka M (2018) Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1alpha-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines, Nutrients. 10. https:\/\/doi.org\/10.3390\/nu10070841","DOI":"10.3390\/nu10070841"},{"key":"1241_CR38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","volume":"33","author":"P Trivedi","year":"2021","unstructured":"Trivedi P, Wang S, Friedman SL (2021) The Power of Plasticity-Metabolic Regulation of Hepatic Stellate Cells. Cell Metab 33:242\u2013257. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.026","journal-title":"Cell Metab"},{"key":"1241_CR39","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41419-022-05409-0","volume":"13","author":"X Yin","year":"2022","unstructured":"Yin X, Peng J, Gu L, Liu Y, Li X, Wu J et al (2022) Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis. Cell Death Dis 13:955. https:\/\/doi.org\/10.1038\/s41419-022-05409-0","journal-title":"Cell Death Dis"},{"key":"1241_CR40","doi-asserted-by":"publisher","first-page":"D1211","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma J, Chen T, Wu S, Yang C, Bai M, Shu K et al (2019) iProX: an integrated proteome resource. Nucleic Acids Res 47:D1211\u2013D1217. https:\/\/doi.org\/10.1093\/nar\/gky869","journal-title":"Nucleic Acids Res"},{"key":"1241_CR41","doi-asserted-by":"publisher","first-page":"D1522","DOI":"10.1093\/nar\/gkab1081","volume":"50","author":"T Chen","year":"2022","unstructured":"Chen T, Ma J, Liu Y, Chen Z, Xiao N, Lu Y et al (2022) iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids Res 50:D1522\u2013D1527. https:\/\/doi.org\/10.1093\/nar\/gkab1081","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01241-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-026-01241-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01241-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:35:48Z","timestamp":1791340548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-026-01241-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1241"],"URL":"https:\/\/doi.org\/10.1007\/s13105-026-01241-8","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"103"}}